Literature DB >> 19373939

Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging.

Sjef Copray1, Jimmy Long Huynh, Falak Sher, Patrizia Casaccia-Bonnefil, Erik Boddeke.   

Abstract

The process of oligodendrocyte differentiation is regulated by a dynamic interaction between a genetic and an epigenetic program. Recent studies, addressing nucleosomal histone modifications have considerably increased our knowledge regarding epigenetic regulation of gene expression during oligodendrocyte development and aging. These results have generated new hypotheses regarding the mechanisms underlying the decreased efficiency of endogenous remyelination in response to demyelinating injuries with increasing age. In this review, we present an overview of the epigenetic mechanisms regulating gene expression at specific stages of oligodendrocyte differentiation and maturation as well as the changes that occur with aging. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19373939      PMCID： PMC2760733          DOI： 10.1002/glia.20881

Source DB:  PubMed          Journal:  Glia        ISSN： 0894-1491            Impact factor:   7.452


  96 in total

Review 1.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 2.  Is there a code embedded in proteins that is based on post-translational modifications?

Authors:  Robert J Sims; Danny Reinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09-11       Impact factor: 94.444

3.  The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein.

Authors:  D D Wood; M A Moscarello
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

Review 4.  Structural dynamics of protein lysine methylation and demethylation.

Authors:  Xiaodong Cheng; Xing Zhang
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

5.  Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination.

Authors:  S A Shields; J M Gilson; W F Blakemore; R J Franklin
Journal:  Glia       Date:  1999-10       Impact factor: 7.452

6.  Multiple roles of Id4 in developmental myelination: predicted outcomes and unexpected findings.

Authors:  Mireya Marin-Husstege; Ye He; Jiadong Li; Toru Kondo; Fred Sablitzky; Patrizia Casaccia-Bonnefil
Journal:  Glia       Date:  2006-09       Impact factor: 7.452

7.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

Review 8.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

9.  Proteolipid protein is required for transport of sirtuin 2 into CNS myelin.

Authors:  Hauke B Werner; Katja Kuhlmann; Siming Shen; Marina Uecker; Anke Schardt; Kalina Dimova; Foteini Orfaniotou; Ajit Dhaunchak; Bastian G Brinkmann; Wiebke Möbius; Lenny Guarente; Patrizia Casaccia-Bonnefil; Olaf Jahn; Klaus-Armin Nave
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

Review 10.  Oligodendrocyte wars.

Authors:  William D Richardson; Nicoletta Kessaris; Nigel Pringle
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870
View more
  41 in total

Review 1.  Epigenetics components of aging in the central nervous system.

Authors:  Yue-Qiang Zhao; I King Jordan; Victoria V Lunyak
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

2.  Genetics meets epigenetics: HDACs and Wnt signaling in myelin development and regeneration.

Authors:  Huiliang Li; William D Richardson
Journal:  Nat Neurosci       Date:  2009-07       Impact factor: 24.884

Review 3.  Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction.

Authors:  Nilkantha Sen
Journal:  Neuromolecular Med       Date:  2014-04-29       Impact factor: 3.843

Review 4.  Mechano-modulation of nuclear events regulating oligodendrocyte progenitor gene expression.

Authors:  Eric Tsai; Patrizia Casaccia
Journal:  Glia       Date:  2019-02-08       Impact factor: 7.452

Review 5.  Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline.

Authors:  Steven G Kohama; Douglas L Rosene; Larry S Sherman
Journal:  Age (Dordr)       Date:  2011-12-28

6.  HOTAIR but not ANRIL long non-coding RNA contributes to the pathogenesis of multiple sclerosis.

Authors:  Majid Pahlevan Kakhki; Abbas Nikravesh; Zeinab Shirvani Farsani; Mohammad Ali Sahraian; Mehrdad Behmanesh
Journal:  Immunology       Date:  2017-11-16       Impact factor: 7.397

7.  Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.

Authors:  Xiomara Pedre; Fabrizio Mastronardi; Wolfgang Bruck; Gerardo López-Rodas; Tanja Kuhlmann; Patrizia Casaccia
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

Review 8.  Comparative epigenomics: defining and utilizing epigenomic variations across species, time-course, and individuals.

Authors:  Shu Xiao; Xiaoyi Cao; Sheng Zhong
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2014-07-15

9.  EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Rev Esp Escler Mult       Date:  2014-03

10.  Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation.

Authors:  Joseph J Abrajano; Irfan A Qureshi; Solen Gokhan; Deyou Zheng; Aviv Bergman; Mark F Mehler
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.